X-154477945-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -9 ACMG points: 0P and 9B. BP4_StrongBP7BS2
The NM_006014.5(LAGE3):āc.431A>Gā(p.Ter144Ter) variant causes a stop retained change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000058 in 1,207,922 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.0000089 ( 0 hom., 0 hem., cov: 24)
Exomes š: 0.0000055 ( 0 hom. 2 hem. )
Consequence
LAGE3
NM_006014.5 stop_retained
NM_006014.5 stop_retained
Scores
2
Clinical Significance
Conservation
PhyloP100: -0.843
Genes affected
LAGE3 (HGNC:26058): (L antigen family member 3) This gene belongs to the ESO/LAGE gene family, members of which are clustered together on chromosome Xq28, and have similar exon-intron structures. Unlike the other family members which are normally expressed only in testis and activated in a wide range of human tumors, this gene is ubiquitously expressed in somatic tissues. The latter, combined with the finding that it is highly conserved in mouse and rat, suggests that the encoded protein is functionally important. An intronless pseudogene with high sequence similarity to this gene is located on chromosome 9. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -9 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP7
Synonymous conserved (PhyloP=-0.843 with no splicing effect.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LAGE3 | NM_006014.5 | c.431A>G | p.Ter144Ter | stop_retained_variant | 3/3 | ENST00000357360.5 | NP_006005.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
LAGE3 | ENST00000357360.5 | c.431A>G | p.Ter144Ter | stop_retained_variant | 3/3 | 1 | NM_006014.5 | ENSP00000349923.4 |
Frequencies
GnomAD3 genomes AF: 0.00000887 AC: 1AN: 112715Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34873
GnomAD3 genomes
AF:
AC:
1
AN:
112715
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34873
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000164 AC: 3AN: 182602Hom.: 0 AF XY: 0.0000149 AC XY: 1AN XY: 67272
GnomAD3 exomes
AF:
AC:
3
AN:
182602
Hom.:
AF XY:
AC XY:
1
AN XY:
67272
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000548 AC: 6AN: 1095207Hom.: 0 Cov.: 29 AF XY: 0.00000555 AC XY: 2AN XY: 360683
GnomAD4 exome
AF:
AC:
6
AN:
1095207
Hom.:
Cov.:
29
AF XY:
AC XY:
2
AN XY:
360683
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00000887 AC: 1AN: 112715Hom.: 0 Cov.: 24 AF XY: 0.00 AC XY: 0AN XY: 34873
GnomAD4 genome
AF:
AC:
1
AN:
112715
Hom.:
Cov.:
24
AF XY:
AC XY:
0
AN XY:
34873
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jul 05, 2022 | This variant has not been reported in the literature in individuals affected with LAGE3-related conditions. This variant is present in population databases (rs782596808, gnomAD 0.008%). This sequence change affects codon 144 of the LAGE3 mRNA. It is a 'silent' change, meaning that it does not change the encoded amino acid sequence of the LAGE3 protein. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the effect of this variant on mRNA splicing is currently unknown. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at